Endoscopic resection of a large ileal lipoma

Apr 12, 2010

A research team from Japan reported a case of a large lipoma, 50 mm in diameter, in the terminal ileum, which was completely removed by a combination of the so-called endoscopic unroofing technique and endoscopic submucosal dissection.

Lipoma is relatively common in the colon but is less often in the . Most lipomas are incidentally detected at and are usually small and asymptomatic. However, some of them can present with obstruction and/or intussusceptions. Surgical resection is commonly recommended to remove such significant lipomas with a limited pedicle and larger than 2 cm in size, as endoscopic resection may result in unfavorable complications such as intestinal perforations.

A research article to be published on April 7, 2010 in the addresses this question. The endoscopic submucosal dissection (ESD) technique was used to remove a large lesion en bloc.

Their results showed large ileal lipoma can be completely removed with the modified ESD procedure in combination with endoscopic unroofing technique (from the top to the bottom like peeling a banana).

Explore further: Unique study focuses on combined treatment approach for locally advanced pancreatic cancer

More information: Morimoto T, Fu KI, Konuma H, Izumi Y, Matsuyama S, Ogura K, Miyazaki A, Watanabe S. Peeling a giant ileal lipoma with endoscopic unroofing and endoscopic submucosal dissection. www.wjgnet.com/1007-9327/full/v16/i13/1676.htm

add to favorites email to friend print save as pdf

Related Stories

Cardia resection for perforated gastroesophageal cancer

Jul 08, 2009

Iatrogenic perforation of cancer of the esophagus or the gastroesophageal (GE) junction is a severe complication. Its incidence has increased most likely because of more aggressive palliative endoscopic therapy and the current ...

Recommended for you

Cancerous tumors may spread by pure chance

6 hours ago

The spreading of a cancerous tumor from one part of the body to another may occur through pure chance instead of key genetic mutations, a new study has shown.

Lanreotide improves survival with enteropancreatic tumors

23 hours ago

(HealthDay)—Lanreotide significantly improves survival among patients with metastatic enteropancreatic neuroendocrine tumors (grade 1 or 2), according to a study published in the July 17 issue of the New En ...

User comments : 0